On ECHEMI
Home > Drugs > Hydatidiform mole
Hydatidiform mole
The so-called hydatidiform mole is the edema and degeneration of the villi that make up the placenta, forming many blisters of varying sizes, like bunches of grapes. The incidence of hydatidiform mole accounts for about one thousandth of the total number of pregnancies, and it most often occurs in women who become pregnant after the age of 40, especially menopausal women. Hydatidiform mole is the disappearance of microvessels in the villous matrix, resulting in accumulation of fluid in the villous matrix, forming bubbles of varying sizes, resembling grapes. There are complete and partial hydatidiform moles, and most of them are complete hydatidiform moles. The clinical diagnosis of hydatidiform mole refers to complete hydatidiform mole; partial hydatidiform mole accompanied by placental tissue and/or fetus is called partial hydatidiform mole. In the tissue of spontaneous abortion, 40% of patients were found to have certain vesicular degeneration, but they were not diagnosed as hydatidiform mole.
  • Site of disease:

    Uterus
  • Infectious :

    Not contagious
  • Frequent population:

    Pregnant women
  • Related symptoms:

    Abdominal pain abnormal enlargement of the uterus during pregnancy luteinized cyst vaginal bleeding lower abdominal distension and pain
Related Drugs
Gynecological Ten Tablets
Manufacturer:

Jiuzhitang Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Zhejiang Zhebei Pharmaceutical Co., Ltd.

Fluorouracil Tablets
Indication: It is the main chemotherapy drug for malignant hydatidiform mole and choriocarcinoma. It is also used for adjuvant chemotherapy and palliative treatment of breast cancer, digestive tract tumors (including primary and metastatic liver cancer and pancreatic cancer), ovarian cancer and primary bronchial lung cancer.
Manufacturer:

Hainan General Alliance Pharmaceutical Co., Ltd.

Fluorouracil Tablets
Indication: It is the main chemotherapy drug for malignant hydatidiform mole and choriocarcinoma. It is also used for adjuvant chemotherapy and palliative treatment of breast cancer, digestive tract tumors (including primary and metastatic liver cancer and pancreatic cancer), ovarian cancer and primary bronchial lung cancer.
Manufacturer:

Xiuzheng Pharmaceutical Group Co., Ltd.

Fluorouracil Tablets
Indication: It is the main chemotherapy drug for malignant hydatidiform mole and choriocarcinoma. It is also used for adjuvant chemotherapy and palliative treatment of breast cancer, digestive tract tumors (including primary and metastatic liver cancer and pancreatic cancer), ovarian cancer and primary bronchial lung cancer.
Manufacturer:

Shanxi Xinyu Pharmaceutical Co., Ltd.

  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.